Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IDEAYA Biosciences (IDYA) Equity Average (2019 - 2025)

IDEAYA Biosciences (IDYA) has disclosed Equity Average for 7 consecutive years, with $1.1 billion as the latest value for Q4 2025.

  • Quarterly Equity Average fell 5.56% to $1.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 billion through Dec 2025, down 5.56% year-over-year, with the annual reading at $1.0 billion for FY2025, 23.92% up from the prior year.
  • Equity Average hit $1.1 billion in Q4 2025 for IDEAYA Biosciences, up from $1.0 billion in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $1.1 billion in Q4 2024 to a low of $215.7 million in Q1 2021.
  • Historically, Equity Average has averaged $606.3 million across 5 years, with a median of $461.3 million in 2023.
  • Biggest five-year swings in Equity Average: soared 127.79% in 2024 and later fell 5.56% in 2025.
  • Year by year, Equity Average stood at $309.6 million in 2021, then rose by 16.0% to $359.1 million in 2022, then soared by 57.21% to $564.6 million in 2023, then surged by 98.34% to $1.1 billion in 2024, then fell by 5.56% to $1.1 billion in 2025.
  • Business Quant data shows Equity Average for IDYA at $1.1 billion in Q4 2025, $1.0 billion in Q3 2025, and $991.9 million in Q2 2025.